Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How? - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2018

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Taycir Skhiri
  • Fonction : Auteur
Emmanuelle Gormally
Pascal Boucher
  • Fonction : Auteur

Résumé

Lung cancer is the major cause of death from cancer in the world and its incidence is increasing in women. Despite the progress made in developing immunotherapies and therapies targeting genomic alterations, improvement in the survival rate of advanced stages or metastatic patients remains low. Thus, urgent development of effective therapeutic molecules is needed. The discovery of novel therapeutic targets and their validation requires high quality biological material and associated clinical data. With this aim, we established a biobank dedicated to lung cancers. We describe here our strategy and the indicators used and, through an overall assessment, present the strengths, weaknesses, opportunities and associated risks of this biobank.
Fichier principal
Vignette du fichier
cancers-10-00220-v2.pdf (2.67 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01834086 , version 1 (18-07-2019)

Licence

Paternité

Identifiants

Citer

Kevin Washetine, Simon Heeke, Christelle Bonnetaud, Mehdi Kara-Borni, Marius Ilié, et al.. Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?. Cancers, 2018, 10 (7), pp.E220. ⟨10.3390/cancers10070220⟩. ⟨hal-01834086⟩
120 Consultations
138 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More